FindTrial
Sign In

Association between metabolic dysfunction-associated fatty liver disease (MAFLD) and extrahepatic diseases: an ambispective cohort study

Association between metabolic dysfunction-associated fatty liver disease (MAFLD) and extrahepatic diseases: an ambispective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058543
Enrollment
Unknown
Registered
2022-04-10
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic dysfunction-associated fatty liver disease

Interventions

case series:NA

Sponsors

The People's Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years; 2. Patients undergoing abdominal B-ultrasound examination in hospital; 3. Medical records of electronic system have at least 2 previous visits; 4. Volunteer to sign informed consent and complete follow-up plan.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumor. 2. Patients with serious primary diseases such as heart, brain, kidney, hematopoietic system and gastrointestinal tract. 3. Other conditions deemed unsuitable for inclusion by the researchers.

Design outcomes

Primary

MeasureTime frame
Malignant tumor;—

Secondary

MeasureTime frame
Coronary heart disease (CHD);Diabetes;Chronic kidney disease (CKD);—

Countries

China

Contacts

Public ContactYang Jianrong

The People's Hospital of Guangxi Zhuang Autonomous Region

1637340358@qq.com+86 13978630882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026